Oct 2026· Ophthalmology Retina· 0 citations· 49 references
Medicine
TL;DR
Structural biomarkers indicate risk for iAMD progression and may differentiate eyes progressing to GA from eyes progressing to nAMD, and needs to be considered in clinical trial design.
Abstract
Purpose
To investigate the prognostic impact of qualitative and quantitative structural biomarkers including their topographic distribution for progression to geographic atrophy (GA) or neovascular age-related macular degeneration (nAMD) in eyes with intermediate AMD (iAMD) within the longitudinal part of the MACUSTAR study (NCT03349801).
Design
Longitudinal, prospective low-interventional European multicenter cohort study.
SUBJECTS
577 eyes of 577 study patients with iAMD.
Methods
Study eyes with iAMD underwent multimodal retinal imaging at each study visit followed by a standardized grading of structural biomarkers, including presence of subretinal drusenoid deposits (SDDs), vitelliform lesion, pigmentary abnormalities (PAs), refractile deposits, pigment epithelium detachment (PED), non-exudative choroidal neovascularization (nCNV), incomplete (i) retinal pigment epithelium and outer retinal atrophy (RORA), complete (c) RORA, and hyperreflective foci presence (HRF). Automated assessment of the retinal pigment epithelium drusen complex (RPEDC) volume and HRF area including their topographic distribution based on spectral-domain optical coherence tomography (OCT) imaging was conducted using a deep-learning based algorithm. Disease progression (GA/nAMD) was assessed at each study visit up to a follow-up time of 4 years. Multivariable time-discrete hazard models were used to evaluate the biomarkers' relevance for disease progression in the entire OCT volume, the central 3 mm disk, and the central subfield of the Early Treatment Diabetes Retinopathy Study (ETDRS) Grid.
MAIN OUTCOME MEASURES
Disease progression to GA/nAMD, hazard ratios of structural biomarkers for disease progression
Results
A total of 577 study eyes of 577 iAMD study patients (mean age 72.01 ± 7.01 years, 66.1 % female, median follow-up 3 years) were included. Disease progression was detected in 82 eyes (9.01 %), 37 (6.4 %) progressed to GA, and 45 (7.7 %) to nAMD. Inside the central 3 mm presence of SDDs, PED, nCNV and cRORA conferred overall risk for progression, whereas PAs, RPEDC volume, iRORA, cRORA were associated with risk for progression to GA. Only nCNV volume increased risk for nAMD.
Conclusions
Structural biomarkers indicate risk for iAMD progression and may differentiate eyes progressing to GA from eyes progressing to nAMD. Biomarker topography impacts their prognostic relevance and needs to be considered in clinical trial design.
PURPOSE
To characterize GA growth and visual outcomes in Asian eyes with geographic atrophy (GA) secondary to age-related macular degeneration and to evaluate the incremental prognostic value of deep learning-derived optical coherence tomography (OCT) biomarkers.
DESIGN
Prospective longitudinal observational cohort s...
K. Teo, Lisa George, A. Forouhari et al.· Ophthalmology Retina· 0 citations
TOPIC
To identify and synthesize clinical, imaging, and treatment-related risk factors associated with retinal pigment epithelium (RPE) tears in neovascular age-related macular degeneration (nAMD).
CLINICAL RELEVANCE
RPE tears are a vision-threatening complication of nAMD, occurring most often in eyes with pigment ep...
S. A. Al-Burak, David Sarraf, F. Naveed et al.· American journal of ophthalm...· 0 citations
OBJECTIVE
To investigate associations between disease-specific OCT biomarkers and pointwise retinal sensitivity (PWS) in retinal vein occlusion (RVO) derived from 2 microperimetry (MP) devices.
DESIGN
Exploratory, prospective, cross-sectional study.
PARTICIPANTS
Twenty eyes of 20 patients with macular edema seconda...
Johannes Schrittwieser, Klaudia Birner, Laetitia Hinterhuber et al.· Canadian Journal of Ophthalm...· 0 citations
Objectives To compare structural optical coherence tomography (OCT) biomarkers and visual acuity between eyes with nonproliferative (NPDR) and proliferative diabetic retinopathy (PDR) in real-life clinical settings. Materials and Methods This retrospective, cross-sectional, multicentre study included 818 eyes of 534 pa...
I. Saygın, Esra Kumral Türkseven, F. B. Kaplan et al.· Turkish journal of ophthalmo...· 0 citations
To determine the detected prevalence of type 4 macular neovascularization (MNV) within a retrospectively screened age-related macular degeneration (AMD) cohort and to characterize its clinical, structural, and angiographic features. This single-center retrospective cohort study included 4658 structural OCT examinations...
M. Bilgeç, M. Özaslan, Ecenur Taş et al.· BMC Ophthalmology· 0 citations
Purpose: To understand the functional impact of macular atrophy (MA) and fibrosis in eyes with treated neovascular age-related macular degeneration (nAMD) based on deep visual sensitivity losses. Design: Cross-sectional study. Participants: One-hundred and nine eyes from 97 individuals with nAMD that had been treated f...
E. K. Glover, R. Guymer, C. J. Abbott et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.